Elucidating the Entry Mechanism of Ebola Viruses
Elucidating the Entry Mechanism of Ebola Viruses
批准号:
7388881
负责人:
Lijun Rong
金额:
$32.21万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-07-01 至 2010-03-31
关键词:
Animal ModelBiochemicalBiochemical GeneticsBiological AssayCell membraneChargeDemocratic Republic of the CongoDiseaseEbola virusFamilyFiloviridaeFoundationsFrankfurt-Marburg Syndrome VirusFutureGenesGlycoproteinsHIVHumanInfectionLaboratoriesLengthLinkMediatingMembrane FusionMolecularPathogenesisPathogenicityPeptidesPlayPrincipal InvestigatorPropertyProtocols documentationReportingResearchRoleSafetySolidSystemSystemic infectionTechniquesTherapeuticTissuesTropismViralViral Hemorrhagic FeversVirionVirusVirus-like particleWorkbasedesigndisulfide bondinhibitor/antagonistmutantnonhuman primateparticlepathogenpositional cloningreceptorreceptor bindingresearch studytherapeutic target
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Ebola and Marburg viruses belong to the family Filoviridae and can cause fatal hemorrhagic fevers characterized by widespread tissue destruction. Because of the safety concerns, these viruses are designated as the bio-safety level 4 agents. Progress in elucidation of the mechanisms of Ebola entry and pathogenesis has been hampered partly due to the safety concern. However, various surrogate systems based on the viral pseudotyping technique have been established to investigate the entry mechanism of Ebola viruses. In this application, we demonstrate that Ebola glycoprotein (GP) can be efficiently incorporated onto HIV viral particles, and the pseudotyped virions are highly infectious, as reported by others. More importantly, we show that we can use this system as a powerful entry assay to elucidate the entry mechanism of Ebola viruses. Our preliminary results clearly illustrate how we can use this pseudotyped system to dissect the roles of both subunits (GP1 and GP2) of Ebola GP in receptor recognition and viral entry. This application will focus on the following specific aims: (1) Characterization of the roles of the charged residues of the GP2 hairpin in Ebola entry. (2) Analysis of the receptor binding region of GP1 in Ebola entry. (3) Identification and characterization of the potential Ebola receptor(s). These studies will provide important information regarding how Ebola GP interacts with the cellular receptor(s) and how Ebola GP mediates efficient membrane fusion and viral entry. Furthermore, elucidation of the roles of GP1 and GP2 in Ebola entry will help us design effective Ebola entry inhibitors which may provide therapeutic treatments against Ebola infection and disease. Therefore, the research work proposed in this application is not only important for elucidating the basic entry mechanism of Ebola viruses, but also important for developing potentially powerful treatments to combat this deadly pathogen.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Optimizing Ridaifen-B analogs as potential therapeutics for Ebola viruses
-
批准号:10586633
-
项目类别:
-
资助金额:$79.52万
-
财政年份:2022
-
负责人:Lijun Rong
-
依托单位:
Optimizing Ridaifen-B analogs as potential therapeutics for Ebola viruses
-
批准号:10708178
-
项目类别:
-
资助金额:$78.02万
-
财政年份:2022
-
负责人:Lijun Rong
-
依托单位:
Furopyrimidines as novel inhibitors of henipaviruses
-
批准号:10327725
-
项目类别:
-
资助金额:$29.97万
-
财政年份:2021
-
负责人:Lijun Rong
-
依托单位:
Development of 4-(aroylamino)piperidine-based entry inhibitors as anti-influenza therapeutics
-
批准号:10576494
-
项目类别:
-
资助金额:$99.94万
-
财政年份:2021
-
负责人:Lijun Rong
-
依托单位:
Development of 4-(aroylamino)piperidine-based entry inhibitors as anti-influenza therapeutics
-
批准号:10256145
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2021
-
负责人:Lijun Rong
-
依托单位:
Development of 4-(aroylamino)piperidine-based entry inhibitors as anti-influenza therapeutics
-
批准号:10618383
-
项目类别:
-
资助金额:$99.94万
-
财政年份:2021
-
负责人:Lijun Rong
-
依托单位:
Development of group 2 influenza A virus entry inhibitors
-
批准号:9903216
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2019
-
负责人:Lijun Rong
-
依托单位:
4-(Aminomethyl) benzamides as novel anti-Ebola agents
-
批准号:10207381
-
项目类别:
-
资助金额:$98.24万
-
财政年份:2016
-
负责人:Lijun Rong
-
依托单位:
4-Aminopiperidines as novel anti-influenza agents
-
批准号:9277398
-
项目类别:
-
资助金额:$15.32万
-
财政年份:2016
-
负责人:Lijun Rong
-
依托单位:
GPCR antagonists as anti-Ebola virus entry inhibitors
-
批准号:8980076
-
项目类别:
-
资助金额:$29.94万
-
财政年份:2015
-
负责人:Lijun Rong
-
依托单位:
GPCR antagonists as anti-Ebola virus entry inhibitors
-
批准号:9090033
-
项目类别:
-
资助金额:$29.77万
-
财政年份:2015
-
负责人:Lijun Rong
-
依托单位:
Novel filovirus entry inhibitors based on a pseudo-symmetrical biphenyl core
-
批准号:8904017
-
项目类别:
-
资助金额:$28.86万
-
财政年份:2015
-
负责人:Lijun Rong
-
依托单位:
New small molecule inhibitors of arenaviruses
-
批准号:8711646
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2014
-
负责人:Lijun Rong
-
依托单位:
New heterocyclic inhibitors of filoviruses
-
批准号:8645994
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2014
-
负责人:Lijun Rong
-
依托单位:
Screening and development of anti-Ebola entry inhibitors
-
批准号:7929493
-
项目类别:
-
资助金额:$89.33万
-
财政年份:2009
-
负责人:Lijun Rong
-
依托单位:
Screening and development of anti-Ebola entry inhibitors
-
批准号:7447165
-
项目类别:
-
资助金额:$119.26万
-
财政年份:2009
-
负责人:Lijun Rong
-
依托单位:
Elucidating the Entry Mechanism of Ebola Viruses
-
批准号:6965281
-
项目类别:
-
资助金额:$32.25万
-
财政年份:2005
-
负责人:Lijun Rong
-
依托单位:
Elucidating the Entry Mechanism of Ebola Viruses
-
批准号:7219488
-
项目类别:
-
资助金额:$32.83万
-
财政年份:2005
-
负责人:Lijun Rong
-
依托单位:
Elucidatng the Entry Mechanism of Ebola Viruses
-
批准号:7086239
-
项目类别:
-
资助金额:$33.81万
-
财政年份:2005
-
负责人:Lijun Rong
-
依托单位:
Elucidating the Entry Mechanism of Ebola Viruses
-
批准号:7580966
-
项目类别:
-
资助金额:$32.21万
-
财政年份:2005
-
负责人:Lijun Rong
-
依托单位:
海外基金